Skip to main content
Top

Open Access 22-05-2025 | Takayasu's Arteriitis | CASE BASED REVIEW

Takayasu arteritis complicated by SAPHO syndrome: A case-based review

Authors: Shu Sugimoto, Dai Kishida, Tatsuya Kobayashi, Naoki Tanomogi, Jun-Ichi Kurashina, Takanori Ichikawa, Yasuhiro Shimojima, Yoshiki Sekijima

Published in: Clinical Rheumatology

Login to get access

Abstract

Takayasu arteritis (TAK) is often associated with other inflammatory diseases. Here, we describe two Japanese patients with TAK complicated by synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome. Both patients presented with anterior chest pain as their chief complaint and were diagnosed with TAK following SAPHO syndrome. Treatment with glucocorticoids and biological agents led to a rapid improvement in symptoms. A review of the literature identified 11 additional cases of TAK complicated by SAPHO syndrome. SAPHO syndrome frequently precedes TAK, with the diagnostic interval between the two diseases ranging from 1 month to 12 years. No clear association was found between the sites of osteoarticular and vascular involvement. These findings suggest that SAPHO syndrome may be a comorbid condition in patients with TAK. As TAK may develop several years after the diagnosis of SAPHO syndrome, clinicians should consider the possibility of TAK in patients presenting with severe inflammation that cannot be fully explained by SAPHO syndrome alone.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Takayasu arteritis complicated by SAPHO syndrome: A case-based review
Authors
Shu Sugimoto
Dai Kishida
Tatsuya Kobayashi
Naoki Tanomogi
Jun-Ichi Kurashina
Takanori Ichikawa
Yasuhiro Shimojima
Yoshiki Sekijima
Publication date
22-05-2025
Publisher
Springer International Publishing
Published in
Clinical Rheumatology
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-025-07501-0

Keynote webinar | Spotlight on advances in lupus

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Learn more about novel biomarkers for diagnosis and monitoring, and familiarize yourself with current and emerging targeted therapies.

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Watch now

EULAR 2025

Explore the latest news and updates from the annual congress of the European Alliance of Associations for Rheumatology.

Read more